Constipation is a common clinical problem encountered in primary care settings, with a prevalence of up to 27% in North America. Despite its frequency, diagnosing and managing constipation can be a complex task due to its multifactorial etiology and the variety of treatment options available.
Constipation can be primarily due to slow colonic transit or disorders of defecation. The former is characterized by infrequent bowel movements, while the latter involves difficulty in evacuation. A thorough understanding of the underlying pathophysiology aids in devising an appropriate diagnostic and therapeutic approach.
Diagnosis primarily relies on the patient's symptoms, supplemented by physical examination and necessary investigations. Rome IV criteria, which includes infrequent bowel movements, straining, lumpy or hard stools, and a sense of incomplete evacuation, is a valuable tool for diagnosis. Investigations like colonoscopy or imaging studies may be required in select cases.
Management should be individualized, considering the patient's symptoms, underlying pathophysiology, and preferences. Lifestyle modifications, including increased dietary fiber and fluid intake, regular exercise, and timely defecation, form the cornerstone of management. Pharmacological interventions, like laxatives, are indicated when lifestyle modifications are insufficient. In refractory cases, biofeedback therapy or surgery may be considered.
Emerging evidence suggests beneficial roles of probiotics in managing constipation. Probiotics can modulate the gut microbiota, enhancing the gut motility and stool consistency. However, further research is needed to establish their routine use in clinical practice.
Constipation is a common but often challenging clinical problem. A comprehensive approach, understanding the underlying pathophysiology, utilizing appropriate diagnostic tools, and individualized management strategies, can effectively manage constipation. Emerging therapies like probiotics offer promising avenues for future research and treatment.
1.
Make the Diagnosis: Can You Explain Her Rash and Conjunctival Injection?
2.
Should the UK introduce targeted prostate cancer screening? The case for and against
3.
Real-World EV Plus Pembro Success Seen in Urothelial Cancer
4.
In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.
5.
Investigating the Relationship Between GERD and Anxiety/Depression.
1.
Building Physical Resilience in Chronic Blood Disorders
2.
Can AI Become Our Oncologic Ally? A Look at Artificial Intelligence in Cancer Detection and Control
3.
Artificial Intelligence for Spatial Tumor Evolution Reconstruction
4.
What are Acanthocytes? Understanding the Role of Spiky Red Blood Cells
5.
Harnessing Cuproptosis: A Novel Nanomedicine Strategy for Triple-Negative Breast Cancer
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
2.
Understanding Risk Factors Associated With Common Cancers
3.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
4.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
5.
The Role of Hemoglobin in Maintaining Healthy Oxygen Levels
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation